Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers: A Pilot Study
Daniel Chernavvsky, MD
Summary
Decision Support System (Software) for multi antidiabetic drug therapy use in type 2 diabetes (T2D).
Description
The purpose of this study is to test the safety and feasibility of using a patient centered decision support system (software) aim for healthcare providers to treat people with type 2 diabetes under multi antidiabetic drug therapy.
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: 1. Age ≥18.0 years old at time of consent. 2. Clinical diagnosis, based on investigator assessment, of type 2 diabetes for at least 6 months. 3. Hemoglobin A1c (HbA1c) ≥ 7.0%. 4. Currently using an approved long-acting insulin for at least 3 months (e.g., insulin glargine, insulin degludec). 5. Treated or about to be treated with multi-drug therapies for T2D. 6. If using a CGM, willingness to wear an additional study CGM during the duration of the study. 7. Access to the internet and willingness to upload data during the study as needed. 8. If female and sexually active, m…
Interventions
- OtherContinuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS)
Continuous Glucose Monitor (CGM) + Patient Centered Multi-Agent Decision Support System (PCM-DSS) PCM-DSS
- OtherContinuous Glucose Monitor (CGM) + Usual Care
Continuous Glucose Monitor (CGM) + Usual Care (Physician)
Location
- University of Virginia Center for Diabetes TechnologyCharlottesville, Virginia